(Q63595912)

English

Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

CareOnTIME (English)

0 references

title

Congenital Adrenal Hyperplasia: Innovative Once Daily Dual Release Hydrocortisone Treatment (English)

0 references

0 references

0 references

congenital adrenal hyperplasia

0 references

start time

11 August 2016

0 references

end time

31 December 2021

0 references

number of participants

150

0 references

research intervention

hydrocortisone acetate

0 references

(±)-adrenaline

0 references

racepinephrine hydrochloride

0 references

epinephryl borate

0 references

Glucocorticoids in hippocampal development

0 references

(RS)-cyclophosphamide

0 references

prednisone

0 references

prednisolone

0 references

Hydrocortisone / Neomycin / Polymyxin B

0 references

clinical trial phase

phase IV clinical trial

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03760835

0 references

(Q63595912)

Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)